Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Myositis
How would you approach continuing monthly IVIG therapy for a patient with anti-HMG-CoA myopathy in remission but recent MI?
Related Questions
How do you approach diagnosis and management of orbital myositis?
Do you routinely perform muscle biopsies in patients presenting with the classic symptoms of Inclusion Body Myositis along with positive CN1A antibody?
In patients with anti-PL7 antibody–associated antisynthetase syndrome, can sacroiliitis occur as part of the inflammatory arthritis spectrum, or should alternative causes be considered?
How do you utilize tools such as MMT8 in clinical practice when evaluating myositis?
What’s your drug of choice for patients with stable antisynthetase NSIP-ILD and overlap RA (CCP+) with significant polyarthritis as main manifestation?
What is the most appropriate next step in management for a patient with dermatomyositis who is maintained on methotrexate 25 mg weekly but develops disease flare when prednisone is tapered below 10 mg daily and is unable to receive IVIG?
How would you approach rituximab dosing in a patient with SLE-Myositis overlap with LN Class III, now with worsening UPCR and concern for worsening ILD 4 months post induction and incomplete B-Cell depletion on recent labs?
Do you consider immunosuppression in patients with a history of Sjogren's disease and clinical features of inclusion body myositis?
How do you approach selecting optimal muscle biopsy site when evaluating a patient for suspected inflammatory myopathy?
What are useful clinical features that help differentiate mechanics hands from other conditions such as hand dermatitis or psoriasis?
